Concepedia

Clint Young

CY

12

Publications

1.4K

Citations

12

H-Index

1997

Active since

Affiliations

Xenon Pharmaceuticals (Canada)(Current)

Shanghai Zhangjiang Laboratory

University of British Columbia

Clint Young is an author at Xenon Pharmaceuticals (Canada) specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

MedicinePharmacologyMolecular PharmacologyPsychiatryNeuroscienceSchizophreniaDrug DiscoveryPharmacotherapyMolecular BiologyNeuropharmacology

Publications per year

1997–2021

12

Publications

12

Loss‐of‐function mutations in the Na <sub>v</sub> 1.7 gene underlie congenital indifference to pain in multiple human populations

Y. Paul Goldberg, Julie MacFarlane, ML MacDonald et al. · Clinical Genetics · 2007 · 448 citations

Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist

Shivani Ahuja, Susmith Mukund, Lunbin Deng et al. · Science · 2015 · 322 citations · Full text

Voltage-gated Sodium, Molecular Biology, Molecular Pharmacology +18

SNAP-25 deficit and hippocampal connectivity in schizophrenia

Clint Young · Cerebral Cortex · 1998 · 174 citations · Full text

Neuropsychology, Psychiatry, Psychotic Disorder +14

Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia

William G. Honer, Peter Falkai, Clint Young et al. · Neuroscience · 1997 · 145 citations

Psychiatry, Neurotransmitter, Molecular Biology +6

Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain

Girish Bankar, Samuel J. Goodchild, Sarah Howard et al. · Cell Reports · 2018 · 75 citations · Full text

Rows per page

1–5 of 12